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Abstract
Retained neuroprotection filter after carotid stenting (CAS) is an extremely rare complication. We report the 
case of a 61-year old patient with an accidentally retained neuroprotection filter after urgent CAS. The patient 
did not consent to open surgical removal of the retained basket. We did not observe any flow disturbances in 
the filter and the patient remains asymptomatic in ten years follow-up. In some cases, the neuroprotection 
filter left in the internal carotid artery may not cause cerebral flow disturbances or occlusion of the stent. In 
case of the poor neurological or general condition of the patient, we can wait for its improvement or stenting.
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Introduction
The use of cerebral protection device (CPD) during CAS 
is a standard procedure [1, 2]. However, using distal 
CPD may be associated with complications [3–5]. Some 
meta-analysis found no evidence that CPD usage was 
associated with reduced perioperative stroke rates [6]. 
Retained neuroprotection filter after stenting of the 
internal carotid artery is an extremely rare complica-
tion but requires reintervention. Instruction for use 
does not include leaving the filter after the procedure 
in the artery.
This article was conducted according to the rec-
ommendations of the CARE — case report guidelines.
Case report
We report herein the case of a patient with a history of 
ischemic stroke, intravenous thrombolysis and stenting 
of the right ICA stenosis complicated by accidentally re-
tained neuroprotection filter above the stent. Informed 
consent has been obtained from the patient for pub-
lication of the case report and accompanying images.
In October 2008, a 61-year-old man suffered a right 
hemispheric stroke (Table 1). Intracranial bleeding was 
excluded on computed tomography (CT). An ischemic 
stroke was confirmed by magnetic resonance imaging 
(MR-DWI). Occlusion of the right ICA was found in 
duplex ultrasound (DUS).
The patient underwent intravenous thrombolysis. 
Alteplase (Actilyse-Boehringer-Ingelheim) — a dose 
of 0.9 mg/kg/h, following a 10 mg intravenous bolus 
injection for one hour. A significant reduction of the 
left hemiparesis was observed. 90% stenosis of the 
right ICA was found in DUS. In the following hours 
the symptoms, however, intensified. Arteriography 
showed occlusion of this artery. Alteplase was therefore 
administered via a vascular sheet positioned in the right 
common carotid artery, in two boluses of 5mg each, 
with an interval of 2 minutes. Repeat arteriogram con-
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firmed patency of the right ICA with 90% stenosis. An 
Accunet (Abbott Vascular) CPD was deployed, followed 
by implantation of an Acculink (Abbott Vascular) 6–8/ 
/30 mm stent. Then we used a recovery catheter and we 
removed it from the carotid artery after (as we thought) 
folding the basket. The patient did not cooperate during 
the procedure and we had no chance to angiographically 
control all this process. During CPD removal, the filter 
and guidewire were disconnected. Filter has stayed in 
artery. Control angiography showed a well-positioned, 
patent stent and excellent cerebral flow. Arteriogram 
also confirmed a retained neuroprotection filter above 
the stent. Due to the poor general and neurological 
condition of the patient no open surgical removal of 
the filter was attempted at this time. 
The patient recovered without important complica-
tions. Clopidogrel (1 × 75 mg), ASA (1 × 75 mg) and 
Enoxaparine (1 × 40 mg) were administered postop-
eratively and he was discharged five days after CAS. 
The patient did not consent to elective filter removal.
DUS performed at 3-month intervals showed 
a patent stent without any relevant stenosis. Control 
CTA was performed in 2013 and 2018 (Fig. 1A). In 
October of 2016, he underwent CAS due to a 75% 
asymptomatic left ICA stenosis, without any compli-
cations. A right ICA angiography showed no evidence 
of stenosis nor migration of the filter (Fig. 1B). Eleven 
years after CAS and retained filter the patient remained 
asymptomatic with patent RICA (Figs 2A, B).
Discussion 
Using a distal CPD during CAS may be challenging 
due to the ICA anatomy, the type of filter and the 
technical skill required of interventionists [7, 8]. The 
most common causes of difficult retrieval of CPD are 
strongly calcified plaques, residual in-stent stenosis, 
carotid tortuosity and re-CAS due to stent fracture 
[9–12]. Neurological complications may occur due to 
vasospasm, filter thrombosis, cerebral embolism or 
carotid artery dissection [13, 14] 
The first choice in the retrieval of entangled CPD is 
endovascular technique, effective in most cases [15, 16]. 
In case of failure, conversion to open surgery is nec-
essary [17–19]. In the available literature, both tech-
niques are burdened with a small percentage of serious 
complications.
Our complication is very rare, but the risk of de-
vice entrapment should be considered during stenting 
procedures. We found a similar case described in the 
ARCHeR3 study [20]. The interventionist implanted 
stent pressing the basket to the artery wall. There was 
no description as to whether IFU was followed at the 
time of surgery. In our case, the neuroprotection basket 
was on the upper edge of the stent. It was against the 
IFU. On the other hand, the patient was not cooperated 
during the procedure, the effect of which basket be-
came entangled with the deployed stent and detached 
from the guide wire during the retrieval attempt. 








Neurological symptoms TIA — weeks before CAS RICA
Stroke — immediately before CAS RICA 
Commorbidities
Nicotinism
Hypertension, Diabetes — insulin dependent
No
Neurological status
NIHSS Scale Modified Rankin Scale
Before trombolysis 11 5
After CAS RICA 5 3
Current status (02.12.2020) 2 1
BMI: body mass index; ABI: ankle brachial index; Hba: glycosylated haemoglobin; TIA: transient ischemic attack; CAS: carotid artery stenting; RICA: right internal  
carotid artery; NIHSS: The National Institutes of Health Stroke Scale
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A guidewire connected to the basket would give 
a chance for endovascular removal of the device.
Filter of the distal CPD is not suitable to leave it in 
situ like, such for example, vena cava filters. According 
to many authors, there is a huge risk of occlusion of 
the filter caused by thrombosis and occlusion of filter 
pores by embolization and hyperplasia. However, these 
observations concern acute, intraoperative occlusion 
[5, 16]. We did not find results regarding late carotid 
filter patency in the literature.
Application of the conversion to the open surgery 
or filter stenting should depend on the condition 
of the patient. Lack of patient cooperation was the 
main factor causing insufficient control in subsequent 
stages of the procedure. In the case of significant flow 
restriction by neuroprotection or the appearance of 
Figure 2. A — retained neuroprotection filter (arrow); B — retained neuroprotection filter (arrow)
Figure 1. A — computed tomography angiography of the right carotid arteries — 10 years after RICA stenting. White arrow — 
a place of the retained filter; B — angiography of the right carotid arteries — 8 years after RICA stenting. Black arrow — a place 
of the retained filter
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neurological symptoms, we will propose the patient 
surgical treatment.
Conclusion
The removal of neuroprotection filter left in carotid 
artery does not have to be done at all costs- in some 
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